ARTICLE | Company News
Cita NeuroPharmaceuticals Inc., Vernalis deal
November 21, 2005 8:00 AM UTC
VER will acquire Cita for $29.5 million in stock. VER also will pay Cita shareholders up to $35 million in stock or cash, contingent upon certain milestones for Cita's CNP1512 melevodopa/carbidopa to...